Intas Pharmaceuticals Ltd - Strategic SWOT Analysis Review

Intas Pharmaceuticals Ltd - Strategic SWOT Analysis Review provides a comprehensive insight into the companys history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the companys key employees, key competitors and major products and services.

This up-to-the-minute company report will help you to formulate strategies to drive your business by enabling you to understand your partners, customers and competitors better.

Scope

- Business description A detailed description of the companys operations and business divisions.
- Corporate strategy summarization of the companys business strategy.
- SWOT analysis A detailed analysis of the companys strengths, weakness, opportunities and threats.
- Company history Progression of key events associated with the company.
- Major products and services A list of major products, services and brands of the company.
- Key competitors A list of key competitors to the company.
- Key employees A list of the key executives of the company.
- Executive biographies A brief summary of the executives employment history.
- Key operational heads A list of personnel heading key departments/functions.
- Important locations and subsidiaries A list of key locations and subsidiaries of the company, including contact details.

Highlights

Intas Pharmaceuticals Ltd (Intas) develops, manufactures, and markets pharmaceuticals and biotechnology products for the treatment of a wide range of diseases and disorders in various therapeutic segments. The company offers products such as sevelamer, ciprofloxacin, amitryptyline, erythropoietin, filgrastim, follicle stimulating hormone (FSH), rituximab, ampicillin, albendazole, benezepril, and caprofen, among others. It also develops recombinant DNA protein (rDNA) products and plasma derived products for oncology, auto-immune, ophthalmology, nephrology and plasma derived product based therapies. It has formulation manufacturing facilities and active pharmaceutical ingredient (API) and intermediate facilities in India. The company markets products through internal sales force and a network of distributors worldwide. Intas is headquartered in Ahmedabad, Gujarat, India.

Reasons to Buy

- Gain key insights into the company for academic or business research purposes. Key elements such as SWOT analysis and corporate strategy are incorporated in the profile to assist your academic or business research needs.
- Identify potential customers and suppliers with this reports analysis of the companys business structure, operations, major products and services and business strategy.
- Understand and respond to your competitors business structure and strategies with detailed SWOT analysis. In this, the companys core strengths, weaknesses, opportunities and threats are analyzed, providing you with an up to date objective view of the company.
- Examine potential investment and acquisition targets with this reports detailed insight into the companys strategic, business and operational performance.

Note: Some sections may be missing if data is unavailable for the company.



Section 1 - About the Company
Intas Pharmaceuticals Ltd - Key Facts
Intas Pharmaceuticals Ltd - Key Employees
Intas Pharmaceuticals Ltd - Major Products and Services
Intas Pharmaceuticals Ltd - History
Intas Pharmaceuticals Ltd - Company Statement
Intas Pharmaceuticals Ltd - Locations And Subsidiaries
Head Office
Other Locations & Subsidiaries
Section 2 Company Analysis
Company Overview
Intas Pharmaceuticals Ltd - Business Description
Intas Pharmaceuticals Ltd - SWOT Analysis
SWOT Analysis - Overview
Intas Pharmaceuticals Ltd - Strengths
Intas Pharmaceuticals Ltd - Weaknesses
Intas Pharmaceuticals Ltd - Opportunities
Intas Pharmaceuticals Ltd - Threats
Intas Pharmaceuticals Ltd - Key Competitors
Section 3 Companys Lifesciences Financial Deals and Alliances
Intas Pharmaceuticals Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2014 to YTD 2020
Intas Pharmaceuticals Ltd, Pharmaceuticals & Healthcare, Deals By Type, 2014 to YTD 2020
Intas Pharmaceuticals Ltd, Recent Deals Summary
Section 4 Appendix
Methodology
About GlobalData
Contact Us
Disclaimer

List Of Tables


Intas Pharmaceuticals Ltd, Key Facts
Intas Pharmaceuticals Ltd, Key Employees
Intas Pharmaceuticals Ltd, Major Products and Services
Intas Pharmaceuticals Ltd, History
Intas Pharmaceuticals Ltd, Other Locations
Intas Pharmaceuticals Ltd, Subsidiaries
Intas Pharmaceuticals Ltd, Key Competitors
Intas Pharmaceuticals Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2014 to YTD 2020
Intas Pharmaceuticals Ltd, Pharmaceuticals & Healthcare, Deals By Type, 2014 to YTD 2020
Intas Pharmaceuticals Ltd, Recent Deals Summary

List Of Figures


Intas Pharmaceuticals Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2014 to YTD 2020
Intas Pharmaceuticals Ltd, Pharmaceuticals & Healthcare, Deals by Type, 2014 to YTD 2020

Intas Pharmaceuticals Ltd - Strategic SWOT Analysis Review

Intas Pharmaceuticals Ltd - Strategic SWOT Analysis Review provides a comprehensive insight into the companys history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information

USD 125 View Report

Intas Pharmaceuticals Ltd Strategic Analysis Review- Intas Pharmaceuticals Ltd SWOT, Outlook, Operations and Financial Profile

Intas Pharmaceuticals Ltd Company Profile provides strategic analysis of Intas Pharmaceuticals Ltd Company in current market conditions. The companys business/ operational/growth strategies are analyzed in the unique research work. Growth

USD 200 View Report

Actelion Pharmaceuticals Ltd - Strategy, SWOT and Corporate Finance Report

Actelion Pharmaceuticals Ltd - Strategy, SWOT and Corporate Finance ReportActelion Pharmaceuticals Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report

USD 175 View Report

Glenmark Pharmaceuticals Ltd (GLENMARK) - Financial and Strategic SWOT Analysis Review

Glenmark Pharmaceuticals Ltd (GLENMARK) - Financial and Strategic SWOT Analysis Review market research report available in single user pdf license with Aarkstore Enterprise at USD 300

USD 300 View Report

Fill The Form For Sample Request

Note : * Kindly provide us with your company id and get the sample reports at the earliest.

There is no Reviews available